These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25354311)

  • 1. Defining molecular initiating events in the adverse outcome pathway framework for risk assessment.
    Allen TE; Goodman JM; Gutsell S; Russell PJ
    Chem Res Toxicol; 2014 Dec; 27(12):2100-12. PubMed ID: 25354311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A History of the Molecular Initiating Event.
    Allen TE; Goodman JM; Gutsell S; Russell PJ
    Chem Res Toxicol; 2016 Dec; 29(12):2060-2070. PubMed ID: 27989138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular target sequence similarity as a basis for species extrapolation to assess the ecological risk of chemicals with known modes of action.
    Lalone CA; Villeneuve DL; Burgoon LD; Russom CL; Helgen HW; Berninger JP; Tietge JE; Severson MN; Cavallin JE; Ankley GT
    Aquat Toxicol; 2013 Nov; 144-145():141-54. PubMed ID: 24177217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the use of in silico methods to predict the chemistry of molecular initiating events related to drug toxicity.
    Ellison CM; Enoch SJ; Cronin MT
    Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1481-95. PubMed ID: 22032332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development and application of adverse outcome pathway in toxicology research].
    Wang Y; Duan H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Dec; 49(12):1115-8. PubMed ID: 26887310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Predictions for Molecular Initiating Events Using Three-Dimensional Quantitative Structure-Activity Relationships.
    Allen TEH; Goodman JM; Gutsell S; Russell PJ
    Chem Res Toxicol; 2020 Feb; 33(2):324-332. PubMed ID: 31517476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse outcome pathway development from protein alkylation to liver fibrosis.
    Horvat T; Landesmann B; Lostia A; Vinken M; Munn S; Whelan M
    Arch Toxicol; 2017 Apr; 91(4):1523-1543. PubMed ID: 27542122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Outcome Pathways-Organizing Toxicological Information to Improve Decision Making.
    Edwards SW; Tan YM; Villeneuve DL; Meek ME; McQueen CA
    J Pharmacol Exp Ther; 2016 Jan; 356(1):170-81. PubMed ID: 26537250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative adverse outcome pathways relevant to neurotoxicity.
    Bal-Price A; Crofton KM; Sachana M; Shafer TJ; Behl M; Forsby A; Hargreaves A; Landesmann B; Lein PJ; Louisse J; Monnet-Tschudi F; Paini A; Rolaki A; Schrattenholz A; Suñol C; van Thriel C; Whelan M; Fritsche E
    Crit Rev Toxicol; 2015 Jan; 45(1):83-91. PubMed ID: 25605028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategy towards the generation of testable adverse outcome pathways for nanomaterials.
    Murugadoss S; Vinković Vrček I; Pem B; Jagiello K; Judzinska B; Sosnowska A; Martens M; Willighagen EL; Puzyn T; Dusinska M; Cimpan MR; Fessard V; Hoet PH
    ALTEX; 2021; 38(4):580-594. PubMed ID: 34008034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Building a Network of Adverse Outcome Pathways (AOPs) Incorporating the Tau-Driven AOP Toward Memory Loss (AOP429).
    Tsamou M; Roggen EL
    J Alzheimers Dis Rep; 2022; 6(1):271-296. PubMed ID: 35891639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.
    Ankley GT; Bennett RS; Erickson RJ; Hoff DJ; Hornung MW; Johnson RD; Mount DR; Nichols JW; Russom CL; Schmieder PK; Serrrano JA; Tietge JE; Villeneuve DL
    Environ Toxicol Chem; 2010 Mar; 29(3):730-41. PubMed ID: 20821501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic understanding of molecular initiating events (MIEs) using NMR spectroscopy.
    Sanderson PN; Simpson W; Cubberley R; Aleksic M; Gutsell S; Russell PJ
    Toxicol Res (Camb); 2016 Jan; 5(1):34-44. PubMed ID: 30090324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Adverse Outcome Pathway (AOP) for forestomach tumors induced by non-genotoxic initiating events.
    Proctor DM; Suh M; Chappell G; Borghoff SJ; Thompson CM; Wiench K; Finch L; Ellis-Hutchings R
    Regul Toxicol Pharmacol; 2018 Jul; 96():30-40. PubMed ID: 29684431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse outcome pathways: opportunities, limitations and open questions.
    Leist M; Ghallab A; Graepel R; Marchan R; Hassan R; Bennekou SH; Limonciel A; Vinken M; Schildknecht S; Waldmann T; Danen E; van Ravenzwaay B; Kamp H; Gardner I; Godoy P; Bois FY; Braeuning A; Reif R; Oesch F; Drasdo D; Höhme S; Schwarz M; Hartung T; Braunbeck T; Beltman J; Vrieling H; Sanz F; Forsby A; Gadaleta D; Fisher C; Kelm J; Fluri D; Ecker G; Zdrazil B; Terron A; Jennings P; van der Burg B; Dooley S; Meijer AH; Willighagen E; Martens M; Evelo C; Mombelli E; Taboureau O; Mantovani A; Hardy B; Koch B; Escher S; van Thriel C; Cadenas C; Kroese D; van de Water B; Hengstler JG
    Arch Toxicol; 2017 Nov; 91(11):3477-3505. PubMed ID: 29051992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of gene × environment interactions on silver nanoparticle toxicity in the respiratory system: An adverse outcome pathway.
    Nicholas TP; Boyes WK; Scoville DK; Workman TW; Kavanagh TJ; Altemeier WA; Faustman EM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1708. PubMed ID: 33768701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular Pathway and AOP Development Using Gene Network Analysis].
    Tanabe S; Hirose A; Whelan M; Yamada T
    Yakugaku Zasshi; 2020; 140(4):485-489. PubMed ID: 32238629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.